Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: System Suitability Testing Parameters Design – V 2.0

Posted on By

Analytical Method Development: System Suitability Testing Parameters Design – V 2.0

SOP for Designing System Suitability Testing Parameters in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/025/2025
Supersedes SOP/AMD/025/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the procedure for designing, validating, and documenting system suitability testing (SST) parameters during the analytical method development phase. System suitability ensures that the analytical system is functioning properly and can produce accurate and precise results prior to sample analysis.

2. Scope

This SOP applies to all chromatographic and spectroscopic analytical methods developed within the Analytical Method Development (AMD) department, including HPLC, GC, UV, and other analytical techniques requiring SST verification before analysis.

3. Responsibilities

  • Analytical Scientist: Proposes SST parameters based on method performance and development data.
  • Team Lead: Reviews justification for SST limits and ensures reproducibility.
  • QA: Confirms SST acceptance criteria are documented and aligned with regulatory guidelines.
  • Head – AMD: Approves final SST parameters for validation and routine application.
See also  Analytical Method Development: Preparation of Method Development Report - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring all SST parameters are defined scientifically, verified through development data, and compliant with ICH, USP, and internal quality systems.

5. Procedure

5.1 Selection of SST Parameters

  1. Define appropriate SST parameters based on the analytical technique and method requirements. Typical parameters include:
    • Chromatography: Resolution (Rs), Tailing Factor (T), Theoretical Plates (N), Retention Time (RT), %RSD of Peak Area
    • Spectroscopy: Absorbance drift, wavelength accuracy, baseline noise
    • General: Signal-to-noise ratio, peak symmetry
  2. Record parameter selection in Annexure-1: SST Parameter Design Sheet.

5.2 Data Collection for SST Limit Definition

  1. Conduct multiple system injections (minimum 6) during development trials.
  2. Use qualified reference or working standard solutions.
  3. Calculate statistical data: Mean, %RSD, min-max range.
  4. Document raw data in Annexure-2: SST Trial Summary Log.

5.3 Establishing Acceptance Criteria

  1. Apply the following general limits unless product-specific requirements dictate otherwise:
    • Resolution (Rs): ≥ 2.0
    • %RSD (Area): ≤ 2.0%
    • Tailing Factor: ≤ 2.0
    • Retention Time: Within ±2% of average
  2. Include rationale for each limit based on method criticality, QbD outcomes, or historical control data.
  3. List final acceptance values in Annexure-3: SST Acceptance Criteria Record.
See also  Analytical Method Development: Handling of Pharmacopoeial Monographs - V 2.0

5.4 Verification and Implementation

  1. Verify SST performance across multiple analysts, instruments, and days.
  2. Ensure repeatability and robustness of system parameters.
  3. Include SST criteria in method validation protocol and report.
  4. Update SOP/AMD/014/2025 (Method Development Report) to include SST design section.

5.5 Deviations and Trending

  1. In case of SST failure:
    • Stop analysis
    • Perform investigation and document deviation
    • Retest with fresh standard or column
  2. QA to evaluate if validation or method modification is required.
  3. Trend SST values monthly using control charts to detect variability.

6. Abbreviations

  • SST: System Suitability Testing
  • Rs: Resolution
  • RSD: Relative Standard Deviation
  • RT: Retention Time
  • QbD: Quality by Design
  • USP: United States Pharmacopeia

7. Documents

  1. SST Parameter Design Sheet – Annexure-1
  2. SST Trial Summary Log – Annexure-2
  3. SST Acceptance Criteria Record – Annexure-3
See also  Analytical Method Development: Review and Approval of Method Development Data - V 2.0

8. References

  • ICH Q2(R2) – Validation of Analytical Procedures
  • USP General Chapter <621> – Chromatography
  • ICH Q14 – Analytical Procedure Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: SST Parameter Design Sheet

Method Parameter Reason for Inclusion
HPLC/AMD/071 Resolution To differentiate API and impurity A
HPLC/AMD/071 %RSD To ensure injection repeatability

Annexure-2: SST Trial Summary Log

Run RT Area Rs Tailing
1 5.83 102304 2.5 1.1
2 5.81 101998 2.4 1.2

Annexure-3: SST Acceptance Criteria Record

Parameter Limit Unit Justification
Resolution ≥ 2.0 — Ensures separation of peaks
%RSD ≤ 2.0 % Acceptable repeatability threshold
Tailing Factor ≤ 2.0 — Ensures peak symmetry

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added annexures and included trending guidance ICH Q14 compliance
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Aerosol: SOP for Installation Qualification (IQ) of Aerosol Manufacturing Equipment – V 2.0
Next Post: Biosimilars: SOP for Handling Genetically Modified Organisms (GMO) – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version